VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GELS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GELSGelteq Limited Ordinary Shares
$0.68$7M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. GELS
  4. Financial Ratios

Gelteq Limited Ordinary Shares (GELS) Financial Ratios

Latest Ratios: P/E Ratio N/A · EV/EBITDA N/A · ROE -21.0%. (2020–2024 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

GELS Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Market Cap$7M—————
Enterprise Value$10M—————
P/E Ratio →——————
P/S Ratio——————
P/B Ratio——————
P/FCF——————
P/OCF——————

P/E links to full P/E history page with 30-year chart

GELS EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020
EV / Revenue——————
EV / EBITDA——————
EV / EBIT——————
EV / FCF——————

GELS Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Gross Margin——38.7%35.7%——
Operating Margin——-3885.3%-2164.4%——
Net Profit Margin——-4391.4%-2283.4%——

Return on Capital

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020
ROE-21.0%-21.0%-17.7%-15.1%-5.4%-168.4%
ROA-16.4%-16.4%-15.3%-14.1%-5.2%-60.7%
ROIC-11.1%-11.1%-10.8%-10.4%-4.1%—
ROCE-15.5%-15.5%-14.3%-13.8%-5.3%—

GELS Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Debt / Equity0.250.250.130.070.010.77
Debt / EBITDA——————
Net Debt / Equity—0.250.110.06-0.00-0.67
Net Debt / EBITDA——————
Debt / FCF——————
Interest Coverage-5.03-5.03-7.69-18.30-499.32—

GELS Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Current Ratio0.080.080.730.671.592.50
Quick Ratio0.080.080.660.581.592.50
Cash Ratio0.010.010.290.150.771.39
Asset Turnover——0.000.01——
Inventory Turnover0.51—0.511.00——
Days Sales Outstanding——1578.49620.14——

GELS Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Dividend Yield——————
Payout Ratio——————

Total Shareholder Return Metrics

MetricTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Earnings Yield——————
FCF Yield——————
Buyback Yield0.0%—————
Total Shareholder Yield0.0%—————
Shares Outstanding—$0$9M$9M$9M$2M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent liquidity and insolvency

Persistent Decay in Capital Returns

As reported in financial statements, Gelteq's ROIC has deteriorated to -3.8% in 2024Q4, reflecting a consistent inability to generate positive returns on invested capital as the company struggles to convert its proprietary gel-based delivery technology into a viable, revenue-generating commercial engine for its stakeholders.

The negative ROIC trend indicates that every dollar of capital deployed is currently destroying shareholder value rather than compounding it. This decay appears structural, as the company lacks the operational scale to offset the high fixed costs associated with its specialized manufacturing and R&D requirements.

Working Capital Management Remains Non-Existent

Based on Gelteq's reported figures, the company's asset turnover has effectively stalled at zero, highlighting a complete lack of operational throughput that prevents the calculation of meaningful efficiency metrics like the cash conversion cycle or inventory turnover in the current pre-revenue environment.

The absence of asset turnover suggests that the company's capital is trapped in non-productive assets, primarily goodwill, rather than being utilized in active manufacturing or distribution. Investors should monitor whether any future pilot programs can generate sufficient volume to establish a measurable and efficient working capital cycle.

Acute Liquidity Crisis Threatens Continuity

According to recent SEC filings, Gelteq's current ratio has plummeted to a precarious 0.08, signaling an extreme inability to meet near-term obligations and suggesting that the firm's survival is entirely dependent on immediate, likely highly dilutive, external capital injections to maintain its basic public listing requirements.

A current ratio of 0.08 is indicative of a company in severe financial distress, as it implies that current liabilities vastly outweigh the available cash and liquid assets. This liquidity position leaves no margin for operational error and suggests that the company may be forced into unfavorable financing terms.

Misleading Reliance on Debt-to-Equity

While the reported debt-to-equity ratio of 0.25% might appear healthy in isolation, analysis of recent filings suggests this metric is fundamentally misapplied to Gelteq, as it obscures the company's total inability to access traditional debt markets due to its lack of cash flow and revenue.

Investors often mistake a low debt-to-equity ratio for financial strength, but in this case, it merely reflects the company's inability to secure leverage. A more appropriate metric for this business model would be the 'cash burn to liquidity' ratio, which highlights the urgent need for equity-based survival funding.

Download Financial Ratios Data

Includes 30+ ratios · 5 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

GELS — Frequently Asked Questions

Quick answers to the most common questions about buying GELS stock.

What is Gelteq Limited Ordinary Shares's ROE?

Gelteq Limited Ordinary Shares's return on equity (ROE) is -21.0%. The historical average is -45.5%.

Is GELS stock overvalued?

Based on historical data, Gelteq Limited Ordinary Shares is trading at valuation metrics that vary. Compare with industry peers and growth rates for a complete picture.